[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371222-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371222-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-pan-cancer-analysis-predictive-role-of-znf32-in-cancer-prognosis-and-immunotherapy-response","A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response","","The zinc finger protein 32 (ZNF32) has been linked to elevated expression across multiple cancers, indicating roles in tumor biology and immune regulation. To clarify ZNF32’s biological function and explore immunotherapy opportunities, a pan-cancer investigation was conducted using public resources including TCGA, CCLE, TIMER2.0, KM-Plotter, cBioPortal, and ImmuCellAI. ZNF32 expression was associated with prognosis, immune infiltration, immunotherapy-related signals, DNA methylation, and cellular functions, and was validated in head and neck cancer cell studies, supporting its potential as a prognostic biomarker and immunotherapy target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-pan-cancer-analysis-predictive-role-of-znf32-in-cancer-prognosis-and-immunotherapy-response/371222/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-pan-cancer-analysis-predictive-role-of-znf32-in-cancer-prognosis-and-immunotherapy-response/371222.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on ZNF32?","Question",{"text":63,"@type":64},"The study investigates ZNF32’s biological role across cancers, especially its relationship with prognosis and immune-related features relevant to immunotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases were used to analyze ZNF32 pan-cancer patterns?",{"text":68,"@type":64},"The analysis used TCGA, CCLE, TIMER2.0, KM-Plotter, cBioPortal, and ImmuCellAI to evaluate expression and correlations with multiple clinical and molecular factors.",{"name":70,"@type":61,"acceptedAnswer":71},"How was ZNF32 validated in experiments?",{"text":72,"@type":64},"In vitro experiments in head and neck cancer (including FaDu and CAL27) assessed immune checkpoint marker changes and tested effects on proliferation, migration, and invasion using assays such as CCK-8, colony formation, flow cytometry, Transwell migration, and Boyden invasion.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371222,1790220086,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Research  \nA pan‑cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response  \nMinghan Li1 · Chang Su1 · Qianru Wang1 · Yuetong Chen2 · Di Jiang3 · Weijia Wang1 · Shunjin Chen3 · Xiangping Li1 · Ming Fu3 · Juan Lu1  \nReceived: 18 October 2024 / Accepted: 13 January 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nThe zinc finger protein 32 (ZNF32) has been associated with high expression in various cancers, underscoring its significant function in both cancer biology and immune response. To further elucidate the biological role of ZNF32 and identify potential immunotherapy targets in cancer, we conducted an in-depth analysis of ZNF32. We comprehensively investigated the expression of ZNF32 across tumors using diverse databases, including TCGA, CCLE, TIMER2.0, KM-Plotter, cBioPortal, ImmuCellAI. We investigated correlations between ZNF32 expression and various factors such as prognosis, immune infiltration, immunotherapy, DNA methylation, and biological functions. Furthermore, we performed in vitro research to validate the significance of ZNF32 in head and neck cancer (HNSC). Our study revealed that ZNF32 was high in various types of cancer, including ACC, BRCA, and others, indicating its important potential as a prognostic biomarker. Significant changes in CNA and DNA methylation were associated with high ZNF32 expression. ZNF32 was notably linked to various immune characteristics, including immune cell infiltration, MSI, TMB and immune checkpoint gene expression, indicating its potential in informing immunotherapy approaches. Interestingly, in FaDu and CAL27 cell lines, the group with elevated ZNF32 expression exhibited increased levels of immune checkpoint markers, such as CTLA-4 and PD-L1 . Overexpression of ZNF32 significantly enhanced proliferation and migration in FaDu and CAL27 cell lines, as demonstrated through CCK-8 assays, colony formation, flow cytometry, Transwell migration, and Boyden invasion assays. Our in vitro experiments confirmed that ZNF32 promotes malignant behavior by driving HNSC cell proliferation and migration. These results imply that ZNF32 might be a promising target for tumor prognosis and immunotherapy. Our results highlight the important role of ZNF32 in tumorigenesis and provide novel perspectives for potential cancer treatment strategies.  \nKeywords ZNF32 · Pan-cancer · Prognosis · Biomarker · Immunotherapy  \nAbbreviations  \nACC Adrenocortical carcinoma BLCA Bladder urothelial carcinoma BRCA Breast invasive carcinoma  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-025-](https://doi.org/10.1007/s12672-025-)[ ](https://doi.org/10.1007/s12672-025-)[01803-0](01803-0.)[.](01803-0.)  \n* Xiangping Li, [li321162@qq.com](li321162@qq.com); * Juan Lu, [lujuanqz@163.com](lujuanqz@163.com); Ming Fu, [fumingchn@163.com |](fumingchn@163.com |1Department)[1](fumingchn@163.com |1Department)[Department](fumingchn@163.com |1Department)  \n[of Otolaryngology-Head and Neck Surgery](of Otolaryngology-Head and Neck Surgery), [Nanfang Hospital](Nanfang Hospital), [Southern Medical University](Southern Medical University), [Guangzhou 510515](Guangzhou 510515), [China](China). 2The First School  \nof Clinical Medicine, Southern Medical University, Guangzhou 510515, China. 3Department of Otolaryngology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan 523000, China.  \nDiscover Oncology  \n(2025) 16:94  \n| [https://doi.org/10.1007/s12672-025-01803-0](https://doi.org/10.1007/s12672-025-01803-0)  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma CHOL Cholangiocarcinoma  \nCOAD Colon adenocarcinoma  \nDLBC Lymphoid neoplasm diffuse large B-cell lymphoma ESCA Oesophageal carcinoma  \nGBM Glioblastoma multiforme  \nHNSC Head and neck squamous cell carcinoma KICH Kidney chromophobe  \nKIRC Kidney renal clear cell carcinoma KIRP Kidney renal papillary cell carcinoma","cbCaibG0yZ01LWVu","https://ap.wps.com/l/cbCaibG0yZ01LWVu","pdf",7673231,18,"English","# Abstract\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What is the main focus of the study on ZNF32?\",\"answer\":\"The study investigates ZNF32’s biological role across cancers, especially its relationship with prognosis and immune-related features relevant to immunotherapy.\"},{\"question\":\"Which databases were used to analyze ZNF32 pan-cancer patterns?\",\"answer\":\"The analysis used TCGA, CCLE, TIMER2.0, KM-Plotter, cBioPortal, and ImmuCellAI to evaluate expression and correlations with multiple clinical and molecular factors.\"},{\"question\":\"How was ZNF32 validated in experiments?\",\"answer\":\"In vitro experiments in head and neck cancer (including FaDu and CAL27) assessed immune checkpoint marker changes and tested effects on proliferation, migration, and invasion using assays such as CCK-8, colony formation, flow cytometry, Transwell migration, and Boyden invasion.\"}]","A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response | PDF",1790191555,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/297e4dd2792ce934e14dc5f55746dc75.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/415a3c360b87a8c1b3cb077c0770288a.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc211d8269d9ccac57a08e5eb87de6ac.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad92da5b05abebc9498767e013d2b5b1.webp",980,1301]